KSKevin L. Stark

Kevin L. Stark

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kevin L. Stark has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Chris R. Kintner

    Departments of Molecular Genetics, 2Pathology, and 3Neurobiology, Amgen, Inc., Thousand Oaks, California 91320 USA; 4Department of Pathology and OB/GYN, Columbia University, College of Physicians and Surgeons, New York, New York 10032 USA; 5Molecular Neurobiology Laboratory, The SALK Institute for Biological Studies, La Jolla, California 90037 USA

    1 shared publication
  • Gisele A. Deblandre

    Departments of Molecular Genetics, 2Pathology, and 3Neurobiology, Amgen, Inc., Thousand Oaks, California 91320 USA; 4Department of Pathology and OB/GYN, Columbia University, College of Physicians and Surgeons, New York, New York 10032 USA; 5Molecular Neurobiology Laboratory, The SALK Institute for Biological Studies, La Jolla, California 90037 USA

    1 shared publication
  • Jan Kitajewski

    Departments of Molecular Genetics, 2Pathology, and 3Neurobiology, Amgen, Inc., Thousand Oaks, California 91320 USA; 4Department of Pathology and OB/GYN, Columbia University, College of Physicians and Surgeons, New York, New York 10032 USA; 5Molecular Neurobiology Laboratory, The SALK Institute for Biological Studies, La Jolla, California 90037 USA

    1 shared publication
  • John R. Shutter

    Departments of Molecular Genetics, 2Pathology, and 3Neurobiology, Amgen, Inc., Thousand Oaks, California 91320 USA; 4Department of Pathology and OB/GYN, Columbia University, College of Physicians and Surgeons, New York, New York 10032 USA; 5Molecular Neurobiology Laboratory, The SALK Institute for Biological Studies, La Jolla, California 90037 USA

    1 shared publication
  • Sheila Scully

    Departments of Molecular Genetics, 2Pathology, and 3Neurobiology, Amgen, Inc., Thousand Oaks, California 91320 USA; 4Department of Pathology and OB/GYN, Columbia University, College of Physicians and Surgeons, New York, New York 10032 USA; 5Molecular Neurobiology Laboratory, The SALK Institute for Biological Studies, La Jolla, California 90037 USA

    1 shared publication
  • Wei Fan

    Departments of Molecular Genetics, 2Pathology, and 3Neurobiology, Amgen, Inc., Thousand Oaks, California 91320 USA; 4Department of Pathology and OB/GYN, Columbia University, College of Physicians and Surgeons, New York, New York 10032 USA; 5Molecular Neurobiology Laboratory, The SALK Institute for Biological Studies, La Jolla, California 90037 USA

    1 shared publication

Latest Publications

  • Open Access

    Dll4, a novel Notch ligand expressed in arterial endothelium

    by John R. Shutter, Sheila Scully, Wei Fan, William G. Richards, Jan Kitajewski, Gisele A. Deblandre, Chris R. Kintner, Kevin L. Stark

    We report the cloning and characterization of a new member of the Delta family of Notch ligands, which we have named Dll4. Like other Delta genes, Dll4 is predicted to encode a membrane-bound ligand, characterized by an extracellular region containing several EGF-like domains and a DSL domain required for receptor binding. In situ analysis reveals a highly selective expression pattern of Dll4 within the vascular endothelium. The activity and expression of Dll4 and the known actions of other members of this family suggest a role for Dll4 in the control of endothelial cell biology.


  • Agrp, a novel gene implicated in the control of feeding

    by Kevin L Stark

    Rapid progress has recently been made to characterise a new pathway involved in the control of feeding behaviour, referred to as the melanocortinergic pathway. Studies of the obese phenotype of the yellow mouse mutant (Ay) suggested the existence of this feeding circuit for some time, but the precise molecular and biochemical regulation was unclear. Through pharmacological and genetic approaches, specific melanocortin receptors expressed within the brain are now known to play a pivotal role. Since receptor agonists decrease food intake, and blocking receptor activity (through antagonists or mutations) increases food intake, this pathway is thought to provide a tonic inhibitory effect on food consumption. A unique feature of this pathway seems to be the regulation of receptor activity by an endogenous protein antagonist, agouti-related protein (AGRP). The molecular characterisation and biochemical activity of this gene suggest that it plays a role in the regulation of feeding behaviour.